Form 8-K Alkermes plc. For: Mar 30

Go back to Form 8-K Alkermes plc. For: Mar 30

Alkermes (ALKS) PT Lowered to $55 at Cowen

April 2, 2018 1:13 PM EDT

Cowen lowered its price target on Alkermes (NASDAQ: ALKS) to $55.00 (from $66.00) while maintaining an Outperform rating following the FDA'S RTF for the NDA for ALKS 5461.

"Amidst uncertainty over potential next steps which will play out over the coming months, out of... More

Alkermes (ALKS) PT Lowered to $45 at Cantor Fitzgerald

April 2, 2018 12:05 PM EDT

Cantor Fitzgerald lowered its price target on Alkermes (NASDAQ: ALKS) to $45.00 (from $50.00) while maintaining a Neutral rating.

... More

Alkermes (ALKS) to Resume Traded at 7:30 am ET

April 2, 2018 7:09 AM EDT

Alkermes (NASDAQ: ALKS) to Resume Traded at 7:30 am ET

... More